Immediate Impact
2 from Science/Nature 58 standout
Citing Papers
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Daijiro Harada being referenced
A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer
2017
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daijiro Harada | 682 | 812 | 353 | 72 | 1.2k | |
| Akihiro Nishiyama | 917 | 777 | 391 | 72 | 1.4k | |
| Judit Moldvay | 585 | 710 | 429 | 77 | 1.2k | |
| Dale R. Shepard | 458 | 463 | 402 | 71 | 1.1k | |
| Takuro Kometani | 589 | 616 | 551 | 43 | 1.2k | |
| Kei Kunimasa | 838 | 774 | 341 | 95 | 1.3k | |
| Ken Suzawa | 551 | 490 | 473 | 79 | 1.1k | |
| Kosuke Tanaka | 809 | 601 | 432 | 83 | 1.4k | |
| Chung-Tsen Hsueh | 296 | 539 | 406 | 53 | 1.1k | |
| Vincenzo Sforza | 351 | 662 | 369 | 58 | 1.1k | |
| Michela Roberto | 334 | 574 | 281 | 75 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...